Andrew Lam - Crunchbase Person Profile

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Investor Type
obfuscated
obfuscation
Investor Stage
obfuscated
obfuscation

Website ally-bridge.com/

Andrew Lam is an investor at Ally Bridge Group leading the therapeutics vertical including investments in Arbor Bio, CARGO Therapeutics, CG Oncology, Endeavor Bio, Rayze Bio, Shoreline Bio and Sonoma Bio. Andrew is a pharmacist by training with two decades of professional experience spanning operating roles in biopharma (medical affairs, business

development) and biopharma-focused corporate finance roles (equity research, investment banking, venture capital).

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Epicrispr Biotechnologies	Ally Bridge Group	Yes	Series B - Epicrispr Biotechnologies	obfuscated obfuscation
obfuscated obfuscation	Endeavor BioMedicines	Ally Bridge Group	—	Series C - Endeavor BioMedicines	obfuscated obfuscation
obfuscated obfuscation	ProfoundBio	Ally Bridge Group	Yes	Series B - ProfoundBio	obfuscated obfuscation
obfuscated obfuscation	Endeavor BioMedicines	Ally Bridge Group	Yes	Series B - Endeavor BioMedicines	obfuscated obfuscation